Today's Research Reports on Cipher Pharmaceuticals Inc., Canopy Growth Corporation, Titan Medical Inc. and Nuvo Pharmaceuticals Inc.
NEW YORK, NY / ACCESSWIRE / August 16, 2017 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at http://rdinvesting.com and get exclusive access to our numerous research reports and market updates.
RDI has Initiated Coverage Today on:
Cipher Pharmaceuticals Inc.
https://ub.rdinvesting.com/news/?ticker=CPH-TO
Canopy Growth Corporation
https://ub.rdinvesting.com/news/?ticker=WEED-TO
Titan Medical Inc.
https://ub.rdinvesting.com/news/?ticker=TMD-TO
Nuvo Pharmaceuticals Inc.
https://ub.rdinvesting.com/news/?ticker=NRI-TO
Cipher Pharmaceuticals Inc.'s stock moved 1.34% higher Tuesday, to close the day at $5.31. The stock recorded a trading volume of 11,150 shares, which was below its three months average volume of 18,435 shares. In the last year Cipher Pharmaceuticals Inc.'s shares have traded in a range of 3.50 - 6.00. The share price has gained 51.71% from its 52 week low. The company's shares are currently trading above their 200-day moving average. Moreover, the stock's 50-day moving average of $5.39 is greater than its 200-day moving average of $4.97. Shares of Cipher Pharmaceuticals have gained approximately 8.37 percent year-to-date.
Access RDI's Cipher Pharmaceuticals Inc. Research Report at:
https://ub.rdinvesting.com/news/?ticker=CPH-TO
On Tuesday, shares in Canopy Growth Corporation recorded a trading volume of 679,279 shares, which was below the three months average volume of 1,081,570 shares. The stock ended the day 0.56% lower at 8.91. The share price has gained 144.11% from its 52 week low with a 52 week trading range of 3.65 - 17.86.The company's shares are currently trading below their 200-day moving average. Moreover, the stock's 50-day moving average of $8.46 is below its 200-day moving average of $9.43. Shares of Canopy Growth have fallen approximately 2.52 percent year-to-date.
Access RDI's Canopy Growth Corporation Research Report at:
https://ub.rdinvesting.com/news/?ticker=WEED-TO
Titan Medical Inc.'s stock moved 3.57% lower Tuesday, to close the day at $0.14. The stock recorded a trading volume of 564,693 shares, which was below its three months average volume of 751,359 shares. In the last year Titan Medical Inc.'s shares have traded in a range of 0.13 - 0.75. The stock is currently trading 82.00% below its 52 week high. The company's shares are currently trading below their 200-day moving average. Moreover, the stock's 50-day moving average of $0.14 is below its 200-day moving average of $0.32. Shares of Titan Medical have fallen approximately 57.81 percent year-to-date.
Access RDI's Titan Medical Inc. Research Report at:
https://ub.rdinvesting.com/news/?ticker=TMD-TO
On Tuesday, shares in Nuvo Pharmaceuticals Inc. recorded a trading volume of 7,095 shares, which was below the three months average volume of 16,610 shares. The stock ended the day flat at 4.00. The stock is currently trading 52.10% below its 52 week high with a 52 week trading range of 3.76 - 8.35.The company's shares are currently trading below their 200-day moving average. Moreover, the stock's 50-day moving average of $4.06 is below its 200-day moving average of $4.88. Shares of Nuvo Pharmaceuticals Inc. are trading at a Price to Earnings ratio of 9.30. Shares of Nuvo Pharmaceuticals have fallen approximately 29.2 percent year-to-date.
Access RDI's Nuvo Pharmaceuticals Inc. Research Report at:
https://ub.rdinvesting.com/news/?ticker=NRI-TO
Our Actionable Research on Cipher Pharmaceuticals Inc. (TSX:CPH.TO), Canopy Growth Corporation (TSX:WEED.TO), Titan Medical Inc. (TSX:TMD.TO) and Nuvo Pharmaceuticals Inc. (TSX:NRI.TO) can be downloaded free of charge at Research Driven Investing.
Research Driven Investing
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.
CONTACT
For any questions, inquiries, or comments reach out to us directly at:
Address:
Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011
Email:
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE: RDInvesting.com
